{"schema_version":"1","generated_at":"2026-10-28T09:34:26.507Z","data_as_of":"2026-10-23","url":"https://www.findmykol.com/kol/seth-karol","json_url":"https://www.findmykol.com/kol/seth-karol/profile.json","record_kind":"full","profile_kind":"clinical","person":{"slug":"seth-karol","name":"Seth Karol","credential":"MD","title":"Associate Member, St. Jude Faculty","specialty":"Hematology / Oncology","specialty_raw":"Pediatric Hematology-Oncology","therapeutic_area":"Leukemia","therapeutic_areas":["Leukemia","Lymphoma"],"institution":"St. Jude Children's Research Hospital","institution_url":"https://www.findmykol.com/institution/st-jude-children-s-research-hospital","city":"Memphis","state":"TN","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"npi":"1437311297","orcid":"0000-0001-8113-8180","openalex":"A5005274385"},"summary":"Seth Karol is Associate Member, St. Jude Faculty at St. Jude Children's Research Hospital. OpenAlex indexes 172 publications with 2,582 citations (h-index 25); ClinicalTrials.gov lists 11 registered studies with this person as an investigator.","overview":{"text":"Seth Karol, M.D., is Associate Member, St. Jude Faculty at St. Jude Children's Research Hospital. The public record shows 172 publications with 2,582 citations (h-index 25), centered on Acute Lymphoblastic Leukemia research, Acute Myeloid Leukemia Research, Chronic Lymphocytic Leukemia Research. It also documents an investigator role on 11 registered clinical trials, industry payments reported by 4 companies, 1 NIH-funded awards (2020–2024).","bullets":["Most recent indexed publication: 2026 · Leukemia","Top research focus: Acute Lymphoblastic Leukemia research","11 registered trials on ClinicalTrials.gov","Open Payments reporting from 4 companies"],"generated_at":"2026-10-27"},"focus":{"indications":[{"label":"Leukemia (AML/ALL/CML/CLL)","therapeutic_area":"Oncology","trials":8,"topics":3,"strength":27},{"label":"Precursor Cell Lymphoblastic Leukemia-Lymphoma","therapeutic_area":"Oncology","trials":5,"topics":0,"strength":15},{"label":"Leukemia, Myeloid, Acute","therapeutic_area":"Oncology","trials":4,"topics":0,"strength":12},{"label":"Lymphoma","therapeutic_area":"Oncology","trials":3,"topics":1,"strength":10},{"label":"Recurrence","therapeutic_area":"Epidemiology","trials":2,"topics":0,"strength":6},{"label":"Hypertension","therapeutic_area":"Cardiology","trials":1,"topics":0,"strength":3},{"label":"Osteonecrosis","therapeutic_area":"Rheumatology/Immunology","trials":1,"topics":0,"strength":3},{"label":"Necrosis","therapeutic_area":"Epidemiology","trials":1,"topics":0,"strength":3},{"label":"Drug-Related Side Effects and Adverse Reactions","therapeutic_area":"Epidemiology","trials":1,"topics":0,"strength":3},{"label":"Pancreatitis","therapeutic_area":"Gastroenterology","trials":1,"topics":0,"strength":3},{"label":"MDS / MPN","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Down Syndrome","therapeutic_area":"Neurology","trials":1,"topics":0,"strength":3},{"label":"Leukemia, Myelomonocytic, Juvenile","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Lymphoma, T-Cell","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3}],"research_topics":["Acute Lymphoblastic Leukemia research","Acute Myeloid Leukemia Research","Chronic Lymphocytic Leukemia Research","Lymphoma Diagnosis and Treatment","Retinoids in leukemia and cellular processes"],"drugs_studied":{"total":3,"shown":3,"withheld":0,"rows":[{"name":"Rylaze","generic":"Asparaginase","trials":0,"payments":5,"publications":7,"mentions":12},{"name":"Venclexta","generic":"Venetoclax","trials":0,"payments":1,"publications":4,"mentions":5},{"name":"Asparlas","generic":"Calaspargase pegol","trials":0,"payments":1,"publications":1,"mentions":2}]},"works_with":{"total":6,"shown":3,"withheld":3,"rows":[{"name":"St. Jude Children's Research Hospital","trials":8,"payments":0,"mentions":8},{"name":"Jazz Pharmaceuticals Inc.","trials":0,"payments":6,"mentions":6},{"name":"PedAL BCU, LLC","trials":2,"payments":0,"mentions":2}]}},"scholarship":{"works_count":172,"cited_by_count":2582,"h_index":25,"i10_index":67,"pubmed_count":43,"latest_activity_year":2026,"source":"works"},"trials":{"count":11,"shown":3,"withheld":8,"matched_by":"identity-adjudicated record","rows":[{"nct":"NCT07008027","title":"Real World Asparaginase Therapy Toxicity","status":"NOT_YET_RECRUITING","role":"Investigator","sponsor":"St. Jude Children's Research Hospital","source_url":"https://clinicaltrials.gov/study/NCT07008027","trial_url":"https://www.findmykol.com/trial/NCT07008027"},{"nct":"NCT06533748","title":"Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma","phase":"PHASE2","status":"RECRUITING","role":"Investigator","sponsor":"St. Jude Children's Research Hospital","source_url":"https://clinicaltrials.gov/study/NCT06533748","trial_url":"https://www.findmykol.com/trial/NCT06533748"},{"nct":"NCT06390319","title":"Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)","phase":"PHASE2","status":"RECRUITING","role":"Investigator","sponsor":"St. Jude Children's Research Hospital","source_url":"https://clinicaltrials.gov/study/NCT06390319","trial_url":"https://www.findmykol.com/trial/NCT06390319"}],"source":"trials"},"payments":{"company_count":4,"program_years":{"first":2021,"last":2025},"rows_total":7,"shown":3,"withheld":4,"rows":[{"payer":"ABBVIE INC.","program_year":2025,"amount_usd":1500,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1437311297"},{"payer":"JAZZ PHARMACEUTICALS INC.","program_year":2025,"amount_usd":273.59,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1437311297"},{"payer":"SERVIER PHARMACEUTICALS LLC","program_year":2024,"amount_usd":4930,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1437311297"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1437311297","source":"payments"},"funding":{"award_count":1,"fiscal_years":{"first":2020,"last":2024},"rows_total":5,"shown":3,"withheld":2,"rows":[{"project":"K08CA250418","title":"Hypertension Intervention to Reduce Osteonecrosis in Children with Acute Lymphoblastic Leukemia","fiscal_year":2024,"amount_usd":224070,"organization":"ST. JUDE CHILDREN'S RESEARCH HOSPITAL","source_url":"https://reporter.nih.gov/quickSearch/K08CA250418"},{"project":"K08CA250418","title":"Hypertension Intervention to Reduce Osteonecrosis in Children with Acute Lymphoblastic Leukemia","fiscal_year":2023,"amount_usd":224070,"organization":"ST. JUDE CHILDREN'S RESEARCH HOSPITAL","source_url":"https://reporter.nih.gov/quickSearch/K08CA250418"},{"project":"K08CA250418","title":"Hypertension Intervention to Reduce Osteonecrosis in Children with Acute Lymphoblastic Leukemia","fiscal_year":2022,"amount_usd":225570,"organization":"ST. JUDE CHILDREN'S RESEARCH HOSPITAL","source_url":"https://reporter.nih.gov/quickSearch/K08CA250418"}],"source":"grants"},"congress":{"count":30,"years":{"first":2005,"last":2026},"societies":["AACR","ASCO","ASH","ASTRO"],"shown":3,"withheld":27,"rows":[{"title":"Abstract 2927: Synthetic lethality of G6PD deficiency and asparaginase for colorectal cancer therapy.","society":"AACR","meeting":"AACR Annual Meeting","year":2026,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1158/1538-7445.am2026-2927","source_url":"https://doi.org/10.1158/1538-7445.am2026-2927","status":"verified"},{"title":"Epigenetic and phenotypic signatures of T-cell response to blinatumomab in pediatric relapsed and refractory B-ALL.","society":"ASCO","meeting":"ASCO Annual Meeting","year":2025,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1200/jco.2025.43.16_suppl.2528","source_url":"https://doi.org/10.1200/jco.2025.43.16_suppl.2528","status":"verified"},{"title":"Clonal evolution of pediatric Acute Myeloid Leukemia","society":"ASH","meeting":"ASH Annual Meeting","year":2025,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1182/blood-2025-1721","source_url":"https://doi.org/10.1182/blood-2025-1721","status":"verified"}],"source":"congress"},"publications":{"total":43,"shown":5,"withheld":38,"matched_by":"ORCID record, linked to PubMed","recent":[{"title":"Traumatic lumbar puncture at diagnosis in children and adolescents with acute lymphoblastic leukemia.","year":2026,"journal":"Leukemia","types":["Letter"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42538430/","status":"verified"},{"title":"Genomic Subtype Influences BH3 Mimetic Drug Sensitivity and Synergy with Cytotoxic Chemotherapeutics in T-cell Acute Lymphoblastic Leukemia.","year":2026,"journal":"Clinical cancer research : an official journal of the American Association for Cancer Research","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/41995729/","status":"verified"},{"title":"Impact of Dosing Interval Adherence on Pharmacokinetic Outcomes of Recombinant Erwinia Asparaginase in Pediatric Leukemia or Lymphoma.","year":2026,"journal":"Pharmacotherapy","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42011546/","status":"verified"},{"title":"Clinical experience of using integrated whole genome and transcriptome sequencing as a framework for pediatric and adolescent acute myeloid leukemia diagnosis and risk assessment.","year":2025,"journal":"Leukemia","types":["Journal Article","Review","Research Support, N.I.H., Extramural"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/41057686/","status":"verified"},{"title":"Clinical Pharmacogenetics Implementation Consortium Guideline for NAT2 Genotype and Hydralazine Therapy.","year":2025,"journal":"Clinical pharmacology and therapeutics","types":["Journal Article","Practice Guideline","Research Support, Non-U.S. Gov't","Research Support, N.I.H., Extramural"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/40974042/","status":"verified"}],"most_cited":{"total":172,"shown":5,"withheld":167,"rows":[{"title":"Venetoclax in combination with cytarabine with or without idarubicin in children with relapsed or refractory acute myeloid leukaemia: a phase 1, dose-escalation study","year":2020,"cited_by_count":164,"type":"article","source_url":"https://doi.org/10.1016/s1470-2045(20)30060-7"},{"title":"NALP3 inflammasome upregulation and CASP1 cleavage of the glucocorticoid receptor cause glucocorticoid resistance in leukemia cells","year":2015,"cited_by_count":162,"type":"article","source_url":"https://doi.org/10.1038/ng.3283"},{"title":"Clinical Significance of Novel Subtypes of Acute Lymphoblastic Leukemia in the Context of Minimal Residual Disease–Directed Therapy","year":2021,"cited_by_count":157,"type":"article","source_url":"https://doi.org/10.1158/2643-3230.bcd-20-0229"},{"title":"Genetics of glucocorticoid-associated osteonecrosis in children with acute lymphoblastic leukemia","year":2015,"cited_by_count":122,"type":"article","source_url":"https://doi.org/10.1182/blood-2015-05-643601"},{"title":"Pharmacotypes across the genomic landscape of pediatric acute lymphoblastic leukemia and impact on treatment response","year":2023,"cited_by_count":98,"type":"article","source_url":"https://doi.org/10.1038/s41591-022-02112-7"}]},"source":"publications"},"network":{"coauthors_total":40,"shown":3,"withheld":37,"coauthors":[{"name":"Ching‐Hon Pui","coauthored_works":95,"profile_url":"https://www.findmykol.com/kol/ching-hon-pui"},{"name":"Hiroto Inaba","coauthored_works":72,"profile_url":"https://www.findmykol.com/kol/hiroto-inaba"},{"name":"Mary V. Relling","coauthored_works":69,"profile_url":"https://www.findmykol.com/kol/mary-relling"}],"source":"works"},"presence":{"owned_accounts":{"total":1,"shown":1,"rows":[{"platform":"doximity","url":"https://www.doximity.com/pub/seth-karol-md","status":"verified"}]},"mentions":{"total":2,"shown":2,"rows":[{"url":"https://www.stjude.org/care-treatment/patient-families/family-caregiver/caregivers-share-podcast/caregivers-share-season-3/what-is-a-clinical-trial.html","platform":"other","status":"verified"},{"url":"https://www.stjude.org/directory/k/seth-karol.html","platform":"other","status":"verified"}]},"verified_means":"confirmed in more than one place; provisional means found and still being confirmed"},"recognition":{"education":{"total":2,"shown":2,"rows":[{"value":"MD, The Ohio State University (Columbus, Ohio)","source_url":"https://stjude.org/karol","status":"verified","collected_at":"2026-10-26"},{"value":"BS, Duke University (Durham, North Carolina)","source_url":"https://stjude.org/karol","status":"verified","collected_at":"2026-10-26"}]},"secondary_affiliations":{"total":5,"shown":3,"rows":[{"value":"Hematological Malignancies Program, St. Jude Children's Research Hospital","source_url":"https://stjude.org/karol","status":"verified","collected_at":"2026-10-26"},{"value":"Leukemia/Lymphoma Division, Department of Oncology, St. Jude Children's Research Hospital","source_url":"https://stjude.org/karol","status":"verified","collected_at":"2026-10-26"},{"value":"Assistant Member, Leukemia & Lymphoma Division, St. Jude Children's Research Hospital [past, per ORCID]","source_url":"https://orcid.org/0000-0001-8113-8180","status":"verified","collected_at":"2026-10-26"}]},"media":{"total":1,"shown":1,"rows":[{"value":"Q&A with Seth Karol, MD: Risk factors for bone toxicity for patients with ALL (HCPLive)","source_url":"https://www.HCPLive.com/view/qa-with-seth-karol-md-risk-factors-for-bone-toxicity-for-patients-with-all-","status":"provisional","collected_at":"2026-10-26"}]}},"similar":[{"name":"Amar Gajjar","slug":"amar-gajjar","institution":"St. Jude Children's Research Hospital","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/amar-gajjar","json_url":"https://www.findmykol.com/kol/amar-gajjar/profile.json"},{"name":"Thomas Merchant","slug":"thomas-merchant","institution":"St. Jude Children's Research Hospital","specialty":"Radiation Oncology","url":"https://www.findmykol.com/kol/thomas-merchant","json_url":"https://www.findmykol.com/kol/thomas-merchant/profile.json"},{"name":"Alberto Pappo","slug":"alberto-pappo","institution":"St. Jude Children's Research Hospital","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/alberto-pappo","json_url":"https://www.findmykol.com/kol/alberto-pappo/profile.json"},{"name":"Gregory Armstrong","slug":"gregory-armstrong","institution":"St. Jude Children's Research Hospital","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/gregory-armstrong","json_url":"https://www.findmykol.com/kol/gregory-armstrong/profile.json"},{"name":"Hagop Kantarjian","slug":"hagop-kantarjian","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/hagop-kantarjian","json_url":"https://www.findmykol.com/kol/hagop-kantarjian/profile.json"},{"name":"Jorge Cortes","slug":"jorge-cortes","institution":"University of Alabama at Birmingham (UAB)","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/jorge-cortes","json_url":"https://www.findmykol.com/kol/jorge-cortes/profile.json"},{"name":"Ayalew Tefferi","slug":"ayalew-tefferi","institution":"Mayo Clinic","specialty":"Hematology","url":"https://www.findmykol.com/kol/ayalew-tefferi","json_url":"https://www.findmykol.com/kol/ayalew-tefferi/profile.json"},{"name":"Charles Sawyers","slug":"charles-sawyers","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/charles-sawyers","json_url":"https://www.findmykol.com/kol/charles-sawyers/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":8,"payments":4,"funding":2,"congress":27,"publications":38,"network":37}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-10-26"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies","collected_at":"2026-10-26"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 to 2025","collected_at":"2026-10-26"},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year","collected_at":"2026-10-26"},"congress":{"name":"OpenAlex","url":"https://openalex.org","provides":"DOI-verified congress abstracts across AACR, ASCO, ASH, ASTRO, ESMO","disclaimer":"Congress abstracts are published as DOI-bearing journal supplements and attributed via the same ORCID-disambiguated authorship as publications.","collected_at":"2026-10-26"},"publications":{"name":"PubMed (NLM)","url":"https://pubmed.ncbi.nlm.nih.gov","provides":"Peer-reviewed publications, linked to the PubMed record","collected_at":"2026-10-26"}},"methodology_url":"https://www.findmykol.com/about#methodology"}